HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth L Frank Selected Research

Elizabeth L Frank Research Topics

Disease

4Pheochromocytoma
08/2021 - 02/2002
3Beriberi
10/2018 - 05/2008
3Neoplasms (Cancer)
05/2017 - 10/2012
2Carcinoid Tumor (Carcinoid)
01/2022 - 01/2017
2Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
01/2022 - 01/2016
2Neoplasm Metastasis (Metastasis)
08/2021 - 01/2016
2Paraganglioma (Paragangliomas)
08/2021 - 02/2002
2Neuroblastoma
05/2017 - 02/2002
1Lennox Gastaut Syndrome
12/2023
1Urolithiasis
12/2023
1Nephrolithiasis
12/2023
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Metabolic Diseases (Metabolic Disease)
01/2021
1Thiamine Deficiency
10/2018
1Hypercalcemia (Milk Alkali Syndrome)
01/2016
1Osteoporosis
01/2016
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2012
1Hypertension (High Blood Pressure)
10/2012
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
05/2008
1Renal Insufficiency (Renal Failure)
07/2002

Drug/Important Bio-Agent (IBA)

4CatecholaminesIBA
01/2022 - 02/2002
3Thiamine (Aneurin)FDA Link
10/2018 - 05/2008
2Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 01/2017
2Homovanillic AcidIBA
01/2022 - 05/2017
2Methylmalonic AcidIBA
01/2022 - 01/2016
2AcidsIBA
01/2022 - 01/2017
2Vanilmandelic Acid (Vanillylmandelic Acid)IBA
01/2022 - 05/2017
2Biomarkers (Surrogate Marker)IBA
08/2021 - 10/2018
2MetanephrineIBA
08/2021 - 12/2013
1Felbamate (Felbatol)FDA Link
12/2023
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Hydroxyindoleacetic AcidIBA
01/2022
1LipidsIBA
10/2021
1NormetanephrineIBA
08/2021
1Dopamine (Intropin)FDA LinkGeneric
08/2021
13-methoxytyramine (methoxytyramine)IBA
08/2021
1Acute Hepatic PorphyriaIBA
01/2021
1Biogenic Amines (Biogenic Amine)IBA
01/2017
1Parathyroid Hormone-Related ProteinIBA
01/2016
1pro-brain natriuretic peptide (1-76)IBA
06/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2014
1Phenytoin (Dilantin)FDA LinkGeneric
07/2002

Therapy/Procedure

1Polypharmacy
12/2023